Нидерландия - нидерландски - myHealthbox

bayer ag - emulgeerbaar concentraat - 25 g/l deltamethrin

Нидерландия - нидерландски - myHealthbox

bayer ag - olie dispersie - 150 g/l spirotetramat

Нидерландия - нидерландски - myHealthbox

bayer ag - suspensie concentraat - 600 g/l aclonifen

Нидерландия - нидерландски - myHealthbox

bayer ag - suspensie concentraat - 200 g/l fluopyram 200 g/l tebuconazool

Нидерландия - нидерландски - myHealthbox

bayer ag - waterdispergeerbaar granulaat - 15.000 iu/mg bacillus thuringiensis subsp. aizawai

Белгия - нидерландски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - 50 mg/ml - concentraat voor oplossing voor infusie - 50 mg/ml - humane anti-t-lymfocyt immunoglobulinen (afkomstig van paarden) 50 mg/ml - antilymphocyte immunoglobulin (horse)

Европейски съюз - нидерландски - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - ophthalmologica - eylea is geïndiceerd bij volwassenen voor de behandeling van:neovascular (natte) leeftijdsgebonden maculaire degeneratie (amd);slechtziendheid als gevolg van maculair oedeem, secundair aan retinale veneuze occlusie (tak rvo of centrale rvo);visuele handicap vanwege diabetisch macula-oedeem (dme);visuele handicap vanwege bijziend choroidale neovascularisation (bijziend cnv).

Европейски съюз - нидерландски - EMA (European Medicines Agency)

csl behring gmbh - humaan normaal immunoglobuline (scig) - immunologic deficiency syndromes - immuun-sera en immunoglobulinen, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacteriële middelen voor systemisch gebruik, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. aandacht moet worden gegeven aan de officiële richtlijnen betreffende het juiste gebruik van antibacteriële agentia.

Нидерландия - нидерландски - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

le vet beheer b.v. - amoxicilline 3-water; amoxicilline 0-water - tablet - amoxicilline 3-water 287,5 mg/stuk; amoxicilline 0-water 250 mg/stuk, - amoxicillin - honden